Article title: Mitoquinone mesylate (MitoQ) prevents sepsis-induced diaphragm dysfunction
Authors: Gerald S. Supinski, Elizabeth A. Schroder, Lin Wang, Andrew J. Morris, Leigh Ann P. Callahan
From the authors: “This is the first study to show that mitoquinone mesylate (MitoQ), a mitochondrially targeted antioxidant, treats sepsis-induced skeletal muscle dysfunction.”
This study is highlighted as one of September’s “best of the best” as part of the American Physiological Society’s APSselect program.
